ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,566.46
1.12%
US Tech 100
19,252.80
-0.27%
Dow Jones
40,421.36
0.33%
Brent Oil
81.865
0.43%
Bitcoin
67,128.24
-0.70%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Moleculin Biotech Inc (MBRX)

  7. Moleculin Biotech Inc (MBRX) News

MBRX

Moleculin Biotech (MBRX)

Moleculin Biotech Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:MBRX
DateTimeSourceHeadlineSymbolCompany
07/22/20245:31PMEdgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:MBRXMoleculin Biotech Inc
07/10/20248:30AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MBRXMoleculin Biotech Inc
07/10/20248:30AMPR Newswire (US)Moleculin Completes End of Phase 2 Meeting with FDA for Annamycin in AMLNASDAQ:MBRXMoleculin Biotech Inc
06/18/20245:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MBRXMoleculin Biotech Inc
06/14/20248:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MBRXMoleculin Biotech Inc
06/14/20248:00AMPR Newswire (US)Moleculin Announces Additional Positive Preliminary Interim Data from AML Clinical TrialNASDAQ:MBRXMoleculin Biotech Inc
06/12/20249:00AMPR Newswire (US)Moleculin to Present at the Virtual Investor Pitch ConferenceNASDAQ:MBRXMoleculin Biotech Inc
06/07/20245:05PMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:MBRXMoleculin Biotech Inc
06/05/20248:55AMPR Newswire (US)Moleculin to Participate in the Virtual Investor Lunch Break SeriesNASDAQ:MBRXMoleculin Biotech Inc
05/16/20248:32AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MBRXMoleculin Biotech Inc
05/16/20248:32AMPR Newswire (US)Moleculin Abstract Accepted for Poster Presentation at the European Hematology Association (EHA) 2024 Hybrid CongressNASDAQ:MBRXMoleculin Biotech Inc
05/15/20248:38AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MBRXMoleculin Biotech Inc
05/15/20248:38AMPR Newswire (US)Moleculin Announces Commencement of NIH-Funded Phase 2 Clinical Trial of STAT3 Inhibitor for the Treatment of Glioblastoma (NU 21C06)NASDAQ:MBRXMoleculin Biotech Inc
05/14/20244:16PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MBRXMoleculin Biotech Inc
05/13/202410:53AMEdgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:MBRXMoleculin Biotech Inc
05/13/20247:30AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MBRXMoleculin Biotech Inc
05/13/20247:30AMPR Newswire (US)Moleculin Reports First Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:MBRXMoleculin Biotech Inc
05/10/20244:30PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MBRXMoleculin Biotech Inc
05/09/20248:30AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MBRXMoleculin Biotech Inc
05/09/20248:30AMPR Newswire (US)Moleculin Announces U.S. Patent Issue Notification for Lipid-Based Delivery Technology for AnnamycinNASDAQ:MBRXMoleculin Biotech Inc
05/08/20248:45AMPR Newswire (US)Moleculin to Report First Quarter 2024 Financial Results on May 10, 2024 and Host Conference Call and WebcastNASDAQ:MBRXMoleculin Biotech Inc
05/08/20248:31AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MBRXMoleculin Biotech Inc
05/07/20244:13PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MBRXMoleculin Biotech Inc
05/07/20248:55AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MBRXMoleculin Biotech Inc
05/07/20248:55AMPR Newswire (US)Moleculin Reports Higher AML Complete Remission (CR) Rates and Significant Durability with Additional Interim Subject DataNASDAQ:MBRXMoleculin Biotech Inc
05/02/20249:00AMPR Newswire (US)Moleculin to Host Virtual AML Clinical Day Featuring Internationally Renowned Clinician, Martin S. Tallman, MD, on May 7, 2024NASDAQ:MBRXMoleculin Biotech Inc
05/01/20248:50AMPR Newswire (US)Moleculin Announces Formation of Scientific Advisory Board to Support Development of AnnamycinNASDAQ:MBRXMoleculin Biotech Inc
04/18/20248:30AMPR Newswire (US)European Medicines Agency (EMA) Grants Orphan Drug Designation for Moleculin's Treatment of Acute Myeloid Leukemia (AML)NASDAQ:MBRXMoleculin Biotech Inc
04/10/20248:30AMPR Newswire (US)Moleculin Announces Presentation of Positive Data Demonstrating High Anti-Cancer Activity of Annamycin and Non-Cardiotoxic PropertiesNASDAQ:MBRXMoleculin Biotech Inc
03/28/202410:45AMPR Newswire (US)Moleculin to Present at the MedInvest Biotech & Pharma Investor ConferenceNASDAQ:MBRXMoleculin Biotech Inc
 Showing the most relevant articles for your search:NASDAQ:MBRX

Your Recent History

USOTC
ITUP
Interups (CE)
USOTC
IDVV
International Endeavors (PK)
NYSE
AMC
AMC Entertainment
USOTC
MGON
Megola (PK)
USOTC
AABB
Asia Broadband (PK)
USOTC
GRLT
Grillit (PK)
USOTC
SHMP
NaturalShrimp (QB)
USOTC
ECSL
Ecare Solutions (PK)
USOTC
CNNA
Cann American (CE)
USOTC
NBRI
North Bay Resources (PK)
USOTC
KBLB
Kraig Biocraft Laborator... (QB)
NASDAQ
LWLG
Lightwave Logic
USOTC
HIRU
Hiru (PK)
USOTC
CGAC
Code Green Apparel (PK)
USOTC
FNMA
Fannie Mae (QB)
USOTC
VPLM
Voip Pal Com (QB)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved